Early Cytokine Signatures of Hospitalized Mild and Severe COVID-19 Patients : A Prospective Observational Study
© 2023 Alfadda et al..
Background: The severe manifestation of coronavirus disease 2019 (COVID-19) is known to be mediated by several cytokines and chemokines. The study aimed to compare the early cytokine profile of mild and severe COVID-19 patients to that with COVID-19-like symptoms and tested negative for Severe Acute Respiratory Syndrome Coronavirus-2 in the Reverse-Transcriptase Polymerase Chain Reaction (RT-PCR) test.
Methods: This was a prospective, observational study on COVID-19 patients admitted to King Khalid University Hospital, King Saud University Medical City from June to November 2020. Clinical and biochemical data were collected from hospital charts. Blood samples were collected at the time of hospital admission to measure cytokines. A Cytokine and Growth Factor High-Sensitivity Array was used to quantitatively measure cytokines.
Results: The study included 202 RT-PCR-positive individuals and 61 RT-PCR-negative individuals. C-Reactive protein (CRP) and Interleukin-10 (IL-10) levels were found significantly elevated in the RT-PCR positive group compared to the RT-PCR negative group (p=0.001). Patients with severe COVID-19 had significantly longer median hospital stays than those with mild COVID-19 cases (7 vs 6 days). They also had higher CRP and Vascular Endothelial Growth Factor (VEGF) levels and lower Interleukin-4 (IL-4) levels compared to the mild cases. CRP, interleukin-6, IL-10, VEGF, and Monocyte Chemoattractant Protein-1 (MCP-1) levels were significantly elevated in men and IL-10 was significantly higher and interleukin-8 was significantly lower in women compared to negative controls. Elevated Interferon-ɣ (IFN-γ) and IL-10 levels were seen in mild COVID-19 cases and elevated level of MCP-1 was seen in severe COVID-19 cases when categorized according to the length of stay in the hospital.
Conclusion: CRP and IL-10 levels were elevated in the RT-PCR positive group. People with severe COVID-19 had higher CRP and VEGF levels and lower IL-4 levels. Elevated IFN-γ and IL-10 levels were seen in mild COVID-19 cases and elevated level of MCP-1 was seen in severe COVID-19 cases when categorized according to the length of stay in the hospital.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
---|---|
Enthalten in: |
Journal of inflammation research - 16(2023) vom: 22., Seite 2631-2643 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Alfadda, Assim A [VerfasserIn] |
---|
Links: |
---|
Themen: |
Asymptomatic patient |
---|
Anmerkungen: |
Date Revised 01.07.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.2147/JIR.S408663 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM358792835 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM358792835 | ||
003 | DE-627 | ||
005 | 20231226075507.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2147/JIR.S408663 |2 doi | |
028 | 5 | 2 | |a pubmed24n1195.xml |
035 | |a (DE-627)NLM358792835 | ||
035 | |a (NLM)37377977 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Alfadda, Assim A |e verfasserin |4 aut | |
245 | 1 | 0 | |a Early Cytokine Signatures of Hospitalized Mild and Severe COVID-19 Patients |b A Prospective Observational Study |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 01.07.2023 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2023 Alfadda et al. | ||
520 | |a Background: The severe manifestation of coronavirus disease 2019 (COVID-19) is known to be mediated by several cytokines and chemokines. The study aimed to compare the early cytokine profile of mild and severe COVID-19 patients to that with COVID-19-like symptoms and tested negative for Severe Acute Respiratory Syndrome Coronavirus-2 in the Reverse-Transcriptase Polymerase Chain Reaction (RT-PCR) test | ||
520 | |a Methods: This was a prospective, observational study on COVID-19 patients admitted to King Khalid University Hospital, King Saud University Medical City from June to November 2020. Clinical and biochemical data were collected from hospital charts. Blood samples were collected at the time of hospital admission to measure cytokines. A Cytokine and Growth Factor High-Sensitivity Array was used to quantitatively measure cytokines | ||
520 | |a Results: The study included 202 RT-PCR-positive individuals and 61 RT-PCR-negative individuals. C-Reactive protein (CRP) and Interleukin-10 (IL-10) levels were found significantly elevated in the RT-PCR positive group compared to the RT-PCR negative group (p=0.001). Patients with severe COVID-19 had significantly longer median hospital stays than those with mild COVID-19 cases (7 vs 6 days). They also had higher CRP and Vascular Endothelial Growth Factor (VEGF) levels and lower Interleukin-4 (IL-4) levels compared to the mild cases. CRP, interleukin-6, IL-10, VEGF, and Monocyte Chemoattractant Protein-1 (MCP-1) levels were significantly elevated in men and IL-10 was significantly higher and interleukin-8 was significantly lower in women compared to negative controls. Elevated Interferon-ɣ (IFN-γ) and IL-10 levels were seen in mild COVID-19 cases and elevated level of MCP-1 was seen in severe COVID-19 cases when categorized according to the length of stay in the hospital | ||
520 | |a Conclusion: CRP and IL-10 levels were elevated in the RT-PCR positive group. People with severe COVID-19 had higher CRP and VEGF levels and lower IL-4 levels. Elevated IFN-γ and IL-10 levels were seen in mild COVID-19 cases and elevated level of MCP-1 was seen in severe COVID-19 cases when categorized according to the length of stay in the hospital | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a asymptomatic patient | |
650 | 4 | |a early inflammation | |
650 | 4 | |a proinflammatory cytokines | |
650 | 4 | |a regulatory cytokines | |
700 | 1 | |a Siddiqui, Khalid |e verfasserin |4 aut | |
700 | 1 | |a Rafiullah, Mohamed |e verfasserin |4 aut | |
700 | 1 | |a AlKhowaiter, Mohammad |e verfasserin |4 aut | |
700 | 1 | |a Alotaibi, Naif |e verfasserin |4 aut | |
700 | 1 | |a Alzahrani, Musa |e verfasserin |4 aut | |
700 | 1 | |a Binkhamis, Khalifa |e verfasserin |4 aut | |
700 | 1 | |a Youssef, Amira M |e verfasserin |4 aut | |
700 | 1 | |a Altalhi, Haifa |e verfasserin |4 aut | |
700 | 1 | |a Almaghlouth, Ibrahim |e verfasserin |4 aut | |
700 | 1 | |a Alarifi, Mohammed |e verfasserin |4 aut | |
700 | 1 | |a Albanyan, Saleh |e verfasserin |4 aut | |
700 | 1 | |a Alosaimi, Mohammed F |e verfasserin |4 aut | |
700 | 1 | |a Isnani, Arthur |e verfasserin |4 aut | |
700 | 1 | |a Nawaz, Shaik S |e verfasserin |4 aut | |
700 | 1 | |a Alayed, Khalid |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of inflammation research |d 2008 |g 16(2023) vom: 22., Seite 2631-2643 |w (DE-627)NLM197692524 |x 1178-7031 |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2023 |g day:22 |g pages:2631-2643 |
856 | 4 | 0 | |u http://dx.doi.org/10.2147/JIR.S408663 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 16 |j 2023 |b 22 |h 2631-2643 |